U
Imagin Medical Inc.
IME
CNSX
E
Sell
3/14/2023Downgrade
Imagin Medical Inc. (IME) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index.
Imagin Medical Inc. (IME) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index.
D
Sell
2/13/2023Upgraded
Imagin Medical Inc. (IME) was upgraded to D from E+ on 2/13/2023 due to a noticeable increase in the growth index, volatility index and total return index. Earnings per share increased from -$0.3445 to $0.0011, EBIT increased 40.9% from -$818.9 to -$484, and operating cash flow increased 27.55% from -$235.6 to -$170.7.
Imagin Medical Inc. (IME) was upgraded to D from E+ on 2/13/2023 due to a noticeable increase in the growth index, volatility index and total return index. Earnings per share increased from -$0.3445 to $0.0011, EBIT increased 40.9% from -$818.9 to -$484, and operating cash flow increased 27.55% from -$235.6 to -$170.7.
E
Sell
2/8/2023Downgrade
Imagin Medical Inc. (IME) was downgraded to E+ from D- on 2/8/2023 due to a decline in the solvency index. The quick ratio declined from 0.02 to 0.
Imagin Medical Inc. (IME) was downgraded to E+ from D- on 2/8/2023 due to a decline in the solvency index. The quick ratio declined from 0.02 to 0.
D
Sell
9/2/2022Upgraded
Imagin Medical Inc. (IME) was upgraded to D- from E+ on 9/2/2022 due to a noticeable increase in the growth index and volatility index. Earnings per share increased from -$0.0907 to $0.3643, and operating cash flow increased 16.9% from -$642.6 to -$534.
Imagin Medical Inc. (IME) was upgraded to D- from E+ on 9/2/2022 due to a noticeable increase in the growth index and volatility index. Earnings per share increased from -$0.0907 to $0.3643, and operating cash flow increased 16.9% from -$642.6 to -$534.
E
Sell
6/6/2022Downgrade
Imagin Medical Inc. (IME) was downgraded to E+ from D- on 6/6/2022 due to a noticeable decline in the growth index, solvency index and total return index. EBIT declined 3.63% from -$601.1 to -$622.9.
Imagin Medical Inc. (IME) was downgraded to E+ from D- on 6/6/2022 due to a noticeable decline in the growth index, solvency index and total return index. EBIT declined 3.63% from -$601.1 to -$622.9.
D
Sell
5/16/2022Upgraded
Imagin Medical Inc. (IME) was upgraded to D- from E+ on 5/16/2022 due to an increase in the volatility index.
Imagin Medical Inc. (IME) was upgraded to D- from E+ on 5/16/2022 due to an increase in the volatility index.
E
Sell
5/1/2022Downgrade
Imagin Medical Inc. (IME) was downgraded to E+ from D- on 5/1/2022 due to a decline in the total return index and volatility index.
Imagin Medical Inc. (IME) was downgraded to E+ from D- on 5/1/2022 due to a decline in the total return index and volatility index.
D
Sell
4/18/2022Downgrade
Imagin Medical Inc. (IME) was downgraded to D- from D on 4/18/2022 due to a decline in the volatility index and total return index.
Imagin Medical Inc. (IME) was downgraded to D- from D on 4/18/2022 due to a decline in the volatility index and total return index.
D
Sell
3/30/2022Upgraded
Imagin Medical Inc. (IME) was upgraded to D from D- on 3/30/2022 due to an increase in the volatility index and total return index.
Imagin Medical Inc. (IME) was upgraded to D from D- on 3/30/2022 due to an increase in the volatility index and total return index.
D
Sell
3/15/2022Downgrade
Imagin Medical Inc. (IME) was downgraded to D- from D on 3/15/2022 due to a decline in the volatility index.
Imagin Medical Inc. (IME) was downgraded to D- from D on 3/15/2022 due to a decline in the volatility index.
D
Sell
2/28/2022Upgraded
Imagin Medical Inc. (IME) was upgraded to D from D- on 2/28/2022 due to an increase in the growth index and volatility index. Earnings per share increased from -$0.7106 to -$0.1091, operating cash flow increased 38.35% from -$1.06M to -$654.5, and EBIT increased 37.52% from -$962.3 to -$601.2.
Imagin Medical Inc. (IME) was upgraded to D from D- on 2/28/2022 due to an increase in the growth index and volatility index. Earnings per share increased from -$0.7106 to -$0.1091, operating cash flow increased 38.35% from -$1.06M to -$654.5, and EBIT increased 37.52% from -$962.3 to -$601.2.
D
Sell
12/27/2021Downgrade
Imagin Medical Inc. (IME) was downgraded to D- from D on 12/27/2021 due to a major decline in the growth index and volatility index. Earnings per share declined from -$0.039 to -$0.7106, operating cash flow declined 40.59% from -$755.1 to -$1.06M, and EBIT declined 34.78% from -$714 to -$962.3.
Imagin Medical Inc. (IME) was downgraded to D- from D on 12/27/2021 due to a major decline in the growth index and volatility index. Earnings per share declined from -$0.039 to -$0.7106, operating cash flow declined 40.59% from -$755.1 to -$1.06M, and EBIT declined 34.78% from -$714 to -$962.3.
D
Sell
11/23/2021Upgraded
Imagin Medical Inc. (IME) was upgraded to D from D- on 11/23/2021.
Imagin Medical Inc. (IME) was upgraded to D from D- on 11/23/2021.
D
Sell
11/8/2021Downgrade
Imagin Medical Inc. (IME) was downgraded to D- from D on 11/8/2021 due to a decline in the volatility index and total return index.
Imagin Medical Inc. (IME) was downgraded to D- from D on 11/8/2021 due to a decline in the volatility index and total return index.
D
Sell
8/20/2021Upgraded
Imagin Medical Inc. (IME) was upgraded to D from D- on 8/20/2021 due to a large increase in the growth index and volatility index. Earnings per share increased from -$0.202 to -$0.039.
Imagin Medical Inc. (IME) was upgraded to D from D- on 8/20/2021 due to a large increase in the growth index and volatility index. Earnings per share increased from -$0.202 to -$0.039.
D
Sell
5/28/2021Downgrade
Imagin Medical Inc. (IME) was downgraded to D- from D on 5/28/2021 due to a noticeable decline in the growth index and solvency index. Earnings per share declined from -$0.0482 to -$0.202, and EBIT declined 42.02% from -$425.7 to -$604.6.
Imagin Medical Inc. (IME) was downgraded to D- from D on 5/28/2021 due to a noticeable decline in the growth index and solvency index. Earnings per share declined from -$0.0482 to -$0.202, and EBIT declined 42.02% from -$425.7 to -$604.6.
D
Sell
1/22/2021Upgraded
Imagin Medical Inc. (IME) was upgraded to D from D- on 1/22/2021 due to an increase in the volatility index and total return index.
Imagin Medical Inc. (IME) was upgraded to D from D- on 1/22/2021 due to an increase in the volatility index and total return index.
D
Sell
1/7/2021Downgrade
Imagin Medical Inc. (IME) was downgraded to D- from D on 1/7/2021 due to a decline in the volatility index.
Imagin Medical Inc. (IME) was downgraded to D- from D on 1/7/2021 due to a decline in the volatility index.
D
Sell
12/23/2020Upgraded
Imagin Medical Inc. (IME) was upgraded to D from D- on 12/23/2020 due to a noticeable increase in the growth index and valuation index. Operating cash flow increased 63.32% from -$494.5 to -$181.4.
Imagin Medical Inc. (IME) was upgraded to D from D- on 12/23/2020 due to a noticeable increase in the growth index and valuation index. Operating cash flow increased 63.32% from -$494.5 to -$181.4.
D
Sell
6/3/2020Downgrade
Imagin Medical Inc. (IME) was downgraded to D- from D on 6/3/2020 due to a decline in the volatility index, growth index and total return index. Operating cash flow declined 56.93% from -$929.1 to -$1.46M, EBIT declined 56.66% from -$791.9 to -$1.24M, and earnings per share declined from -$0.0068 to -$0.0082.
Imagin Medical Inc. (IME) was downgraded to D- from D on 6/3/2020 due to a decline in the volatility index, growth index and total return index. Operating cash flow declined 56.93% from -$929.1 to -$1.46M, EBIT declined 56.66% from -$791.9 to -$1.24M, and earnings per share declined from -$0.0068 to -$0.0082.
D
Sell
5/1/2020Upgraded
Imagin Medical Inc. (IME) was upgraded to D from D- on 5/1/2020 due to an increase in the volatility index and growth index. EBIT increased 14.16% from -$922.5 to -$791.9, and earnings per share increased from -$0.0073 to -$0.0068.
Imagin Medical Inc. (IME) was upgraded to D from D- on 5/1/2020 due to an increase in the volatility index and growth index. EBIT increased 14.16% from -$922.5 to -$791.9, and earnings per share increased from -$0.0073 to -$0.0068.
D
Sell
8/28/2019Downgrade
Imagin Medical Inc. (IME) was downgraded to D- from D on 8/28/2019 due to a decline in the efficiency index, volatility index and growth index. Operating cash flow declined 33.74% from -$617.1 to -$825.3, earnings per share declined from -$0.005 to -$0.0065, and net income declined 28.94% from -$696.6 to -$898.2.
Imagin Medical Inc. (IME) was downgraded to D- from D on 8/28/2019 due to a decline in the efficiency index, volatility index and growth index. Operating cash flow declined 33.74% from -$617.1 to -$825.3, earnings per share declined from -$0.005 to -$0.0065, and net income declined 28.94% from -$696.6 to -$898.2.
D
Sell
6/5/2019Upgraded
Imagin Medical Inc. (IME) was upgraded to D from D- on 6/5/2019 due to an increase in the efficiency index and growth index. Operating cash flow increased 16.71% from -$740.9 to -$617.1, net income increased 9.12% from -$766.5 to -$696.6, and earnings per share increased from -$0.0055 to -$0.005.
Imagin Medical Inc. (IME) was upgraded to D from D- on 6/5/2019 due to an increase in the efficiency index and growth index. Operating cash flow increased 16.71% from -$740.9 to -$617.1, net income increased 9.12% from -$766.5 to -$696.6, and earnings per share increased from -$0.0055 to -$0.005.
D
Sell
3/12/2019Downgrade
Imagin Medical Inc. (IME) was downgraded to D- from D on 3/12/2019 due to a decline in the efficiency index, total return index and volatility index. Total capital declined 12.97% from $4.64M to $4.03M.
Imagin Medical Inc. (IME) was downgraded to D- from D on 3/12/2019 due to a decline in the efficiency index, total return index and volatility index. Total capital declined 12.97% from $4.64M to $4.03M.
D
Sell
12/21/2018Upgraded
Imagin Medical Inc. (IME) was upgraded to D from D- on 12/21/2018 due to an increase in the efficiency index and volatility index.
Imagin Medical Inc. (IME) was upgraded to D from D- on 12/21/2018 due to an increase in the efficiency index and volatility index.
D
Sell
8/17/2018Downgrade
Imagin Medical Inc. (IME) was downgraded to D- from D on 8/17/2018 due to a large decline in the total return index, efficiency index and volatility index.
Imagin Medical Inc. (IME) was downgraded to D- from D on 8/17/2018 due to a large decline in the total return index, efficiency index and volatility index.
D
Sell
4/30/2018Upgraded
Imagin Medical Inc. (IME) was upgraded to D from D- on 4/30/2018 due to an increase in the efficiency index, solvency index and volatility index. The quick ratio increased from 7.64 to 54.29, total capital increased 106.28% from $1.45M to $2.99M, and debt to equity declined from 0.02 to 0.
Imagin Medical Inc. (IME) was upgraded to D from D- on 4/30/2018 due to an increase in the efficiency index, solvency index and volatility index. The quick ratio increased from 7.64 to 54.29, total capital increased 106.28% from $1.45M to $2.99M, and debt to equity declined from 0.02 to 0.
D
Sell
2/20/2018Downgrade
Imagin Medical Inc. (IME) was downgraded to D- from D+ on 2/20/2018 due to a noticeable decline in the growth index, efficiency index and valuation index. Operating cash flow declined 7,092.03% from $13.8 to -$964.9, EBIT declined 243.62% from -$285.9 to -$982.4, and net income declined 235.2% from -$298.3 to -$999.9.
Imagin Medical Inc. (IME) was downgraded to D- from D+ on 2/20/2018 due to a noticeable decline in the growth index, efficiency index and valuation index. Operating cash flow declined 7,092.03% from $13.8 to -$964.9, EBIT declined 243.62% from -$285.9 to -$982.4, and net income declined 235.2% from -$298.3 to -$999.9.
D
Sell
11/16/2017Upgraded
Imagin Medical Inc. (IME) was upgraded to D+ from D on 11/16/2017 due to a substantial increase in the total return index and volatility index.
Imagin Medical Inc. (IME) was upgraded to D+ from D on 11/16/2017 due to a substantial increase in the total return index and volatility index.
D
Sell
10/20/2017None
Imagin Medical Inc. (IME) was downgraded to D from U on 10/20/2017.
Imagin Medical Inc. (IME) was downgraded to D from U on 10/20/2017.
